北京招聘

Key responsibilities:

? Contribute to antibody discovery goals utilizing hybridoma technology for different programs

? Participate in project planning activities including immune strategies and screening cascades design

? Execute experiments to generate monoclonal antibodies, including mice/rat immunization, serum titer evaluation, hybridoma fusion and culture, screening of antibodies, sucbcloning, hybridoma expansion, cryopreservation, antibody purification and other assignments as required

? Be capable of multi-task processing and work on various projects in parallel, and responsible for trouble shooting and delivery task in timely manner

? Interpret and summarize experimental data, present results at project meeting

? Maintain appropriate experimental records and documentation

Qualifications:

? Good experience with antibody generation using hybridoma technology is a must

? Strong experience with antibody binding assays, especially ELISA and FACS is required

? Experience with transgenic animals, high-throughput automation, molecular biology, hybridoma sequencing and B-cell cloning is a plus

? High accountability, collaborative and proactive attitude with multi-task ability

? Proven ability to work independently, troubleshoot, interpret and report data

? Excellent attention to detail, strong documentation skills, and ability to communicate effectively.

Zai Lab is an innovative biopharmaceutical company based in Zhang Jiang, Shanghai focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Zai Lab focus on innovation to meets the unmet medical needs. Zai has built up a strong pipeline with multiple programs on clinical stages. Zai Lab successfully listed on Nasdaq in Sep. 2017.

再鼎医药是一家总部设立于上海张江，致力于研究、开发和销售创新药物的制药企业。再鼎医药针对目前尚无良好治疗手段的疾病领域开发新药，在肿瘤、抗感染、自身免疫等方面建立了全面的产品线，服务中国和全球病患。再鼎医药于2017年9月在美国纳斯达克成功上市。